Author:
Pathak Amita,Singh Bhumika,Chaurasia Dheeraj Kumar,Jayaram B.
Reference60 articles.
1. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020) Features, evaluation and treatment coronavirus (COVID-19). In: Statpearls. Publishing, StatPearls
2. Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, Yuan S, Yuen KY (2020) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microb Infect 9(1):221–236. https://doi.org/10.1080/22221751.2020.1719902
3. Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM et al (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583:459–468. https://doi.org/10.1038/s41586-020-2286-9
4. Gil C, Ginex T, Maestro I, Nozal V, Barrado-Gil L, Cuesta-Geijo MA et al (2020) COVID-19: drug targets and potential treatments. J Med Chem 63:12359. https://doi.org/10.1021/acs.jmedchem.0c00606
5. https://www.biopharmadive.com/news/new-drug-cost-research-development-market-jama-study/573381/. Accessed 26 Sep 2020